Clinical Trial Update: Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining distractibility syndrome in patients with progressive supranuclear palsy; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Supranuclear Palsy

Snippet

Sponsor: Groupe Hospitalier Pitie-Salpetriere | Conditions: Supranuclear Palsy, Progressive | Phase 2 | Status: UNKNOWN